Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne
Author
dc.contributor.author
Gübelin, Walter
Author
dc.contributor.author
Martínez, M. Angélica
Author
dc.contributor.author
Molina, M. Teresa
Author
dc.contributor.author
Zapata, Solange
Author
dc.contributor.author
Valenzuela, M. Eugenia
Admission date
dc.date.accessioned
2019-03-11T12:54:02Z
Available date
dc.date.available
2019-03-11T12:54:02Z
Publication date
dc.date.issued
2006
Cita de ítem
dc.identifier.citation
Revista Latinoamericana de Microbiologia, Volumen 48, Issue 1, 2018, Pages 14-16
Identifier
dc.identifier.issn
01874640
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164323
Abstract
dc.description.abstract
In the last decade, a significant increase in the antimicrobial resistance of clinical specimens of Propionibacterium acnes to first line antibiotics used for acne treatment, has been informed in Europe and in the USA. No information about strains isolated from Latin-American countries is available. The antimicrobial susceptibility of 53 strains of P. acnes isolated from skin specimens of inflammatory acne patients, at the clinical Hospital University of Chile was tested. All isolates were susceptible to penicillin, minocycline, and nadifloxacin. Erythromycin and clindamycin resistance was found in 3.8 and 1.9% isolates respectively. Resistance to lymecycline was observed in one isolate, which was intermediate to tetracycline and doxycycline.